Original document(20 pages)  中文版
    The problems of the present invention are to provide a simple and convenient means for the examination of renal failure and to provide a method for the measurement of a lipid component in urine utilizing the said examining means. Means for solving the problems according to the present invention is a method for the measurement of a lipid component contained in urine which is characterized in using a surface-active agent in a sufficient amount for solubilizing the insoluble fat in urine and in using an enzyme acting the lipid component. It also provides a simple and convenient means for the examination of renal failure by the measurement of a lipid component contained in urine, by the measurement of lipoproteins in urine and/or apoproteins in urine in addition to the above measurement and by a combination of measurement of surface antigen of leukocyte contained in urine therewith.
Application Number
申请号
01804716 Application Date
申请日
2001.02.07
Title 名称 Method of measuring lipid components and method of examining renal failure
Publication Number
公开号
1398350 Publication Date
公开日
2003.02.19
Approval Pub. Date 2007.10.17 Granted Pub. Date 2007.10.17
International Classification 分类号 G01N33/92
Applicant(s) Name
申请人
International Reagents Corp
Address 地址
Inventor(s) Name 发明人 Hotta Osamu;Shirahase Yasushi;Hiura Hisahide
Attorney & Agent 代理人 cao wen meng fanhong
More information 更  多  信  息


 Related patents information
Sublimation purifying method and apparatus
Means of examining nephropathy
Method and device for producing organic EL elements
Fully automatic washing machine
Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.